找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

(版塊PHARMACOLOGY & PHARMACY(藥理學(xué)與藥學(xué))版塊期刊總數(shù):274)
新窗
投票 SCIE期刊MOLECULAR PHARMACEUTICS 2024/2025影響因子:4.515 (MOL PHARMACEUT) (1543-8384). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Scienc  ...234
Total Citations:22661; 2023 JIF:4.515; JIFRank: 60/354 ; Rank-JIF: 60; Number-of-JIF:354; 5 Year JIF:4.677; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:1; Immediacy Index-dealt:1.125; 2023 JCI:1.22; JCI Rank: 56/354 ; Total Articles:414; JCI Quartile:Q1; JCI Percentile:84.32; Eigenfactor:0.015; Normalized Eigenfactor:3.284; Article Influence Score:0.817; JIF Percentile:83.2; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:460; % of Articles in Citable items:0.9; Cited Half-Life:6.4; Citing Half-Life:7; % of OA Gold:0.1279; Publisher name:KOREAN AUDIOLOGICAL SOC; Publisher address:DEPT OTORHINOLARY-HEAD&NECK SURG, SEOUL
投票 SCIE期刊CHEMICO-BIOLOGICAL INTERACTIONS 2024/2025影響因子:4.752 (CHEM-BIOL INTERACT) (0009-2797). (PHARMACOLOGY & PHARMACY)(藥  ...234
Total Citations:17009; 2023 JIF:4.752; JIFRank: 55/354 ; Rank-JIF: 55; Number-of-JIF:354; 5 Year JIF:4.698; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.6; Immediacy Index:1; Immediacy Index-dealt:1.157; 2023 JCI:1.16; JCI Rank: 59/354 ; Total Articles:318; JCI Quartile:Q1; JCI Percentile:83.47; Eigenfactor:0.01; Normalized Eigenfactor:2.279; Article Influence Score:0.773; JIF Percentile:84.6; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:364; % of Articles in Citable items:0.8736; Cited Half-Life:6.6; Citing Half-Life:7.1; % of OA Gold:0.117; Publisher name:AIP PUBLISHING; Publisher address:1305 WALT WHITMAN RD, STE 300, MELVILLE, USA,
投票 SCIE期刊Journal of Pharmaceutical Innovation 2024/2025影響因子:2.775 (J PHARM INNOV) (1872-5120). (PHARMACOLOGY & PHARMACY)(藥  ...234
Total Citations:1556; 2023 JIF:2.775; JIFRank: 167/354 ; Rank-JIF: 167; Number-of-JIF:354; 5 Year JIF:2.825; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:0.5; Immediacy Index-dealt:0.552; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:104; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.001; Normalized Eigenfactor:0.283; Article Influence Score:0.419; JIF Percentile:53; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:104; % of Articles in Citable items:1; Cited Half-Life:3.7; Citing Half-Life:7.8; % of OA Gold:0.1066; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 SCIE期刊MOLECULAR PHARMACOLOGY 2024/2025影響因子:3.284 (MOL PHARMACOL) (0026-895X). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science  ...234
Total Citations:13017; 2023 JIF:3.284; JIFRank: 124/354 ; Rank-JIF: 124; Number-of-JIF:354; 5 Year JIF:3.541; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.7; Immediacy Index-dealt:0.728; 2023 JCI:0.87; JCI Rank: 109/354 ; Total Articles:49; JCI Quartile:Q2; JCI Percentile:69.35; Eigenfactor:0.004; Normalized Eigenfactor:0.906; Article Influence Score:0.997; JIF Percentile:65.1; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:52; % of Articles in Citable items:0.9423; Cited Half-Life:15.9; Citing Half-Life:9.3; % of OA Gold:0.2459; Publisher name:AUSTRALIAN POLITICAL ECONOMY MOVEMENT; Publisher address:UNIV SYDNEY, BOX
投票 SCIE期刊CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2024/2025影響因子:1.794 (CAN J PHYSIOL PHARM) (0008-4212). (PHARMACOL  ...234
Total Citations:4773; 2023 JIF:1.794; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.825; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.2; Immediacy Index-dealt:0.262; 2023 JCI:0.63; JCI Rank: 190/354 ; Total Articles:70; JCI Quartile:Q3; JCI Percentile:28.82; Eigenfactor:0.002; Normalized Eigenfactor:0.443; Article Influence Score:0.346; JIF Percentile:25.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:77; % of Articles in Citable items:0.9091; Cited Half-Life:10; Citing Half-Life:9.3; % of OA Gold:0.0752; Publisher name:FUNDACION VECA PARA AVANCE PSICOLOGIA; Publisher address:APARTADO CORREOS 12
投票 SCIE期刊Journal of Pharmaceutical Investigation 2024/2025影響因子:5.377 (J PHARM INVEST) (2093-5552). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:1721; 2023 JIF:5.377; JIFRank: 34/354 ; Rank-JIF: 34; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:4.9; Immediacy Index:0.5; Immediacy Index-dealt:0.545; 2023 JCI:1.1; JCI Rank: 68/354 ; Total Articles:25; JCI Quartile:Q1; JCI Percentile:80.93; Eigenfactor:0.001; Normalized Eigenfactor:0.283; Article Influence Score:0.419; JIF Percentile:90.5; JIF Quartile:Q1; AIS Quartile:NULL; Citable Items:42; % of Articles in Citable items:0.5952; Cited Half-Life:4.2; Citing Half-Life:7.2; % of OA Gold:0.0467; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊Neurotherapeutics 2024/2025影響因子:5.618 (NEUROTHERAPEUTICS) (1933-7213). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science C  ...234
Total Citations:8591; 2023 JIF:5.618; JIFRank: 31/354 ; Rank-JIF: 31; Number-of-JIF:354; 5 Year JIF:6.993; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.5; Immediacy Index:1.3; Immediacy Index-dealt:1.313; 2023 JCI:1.39; JCI Rank: 35/354 ; Total Articles:65; JCI Quartile:Q1; JCI Percentile:86.29; Eigenfactor:0.01; Normalized Eigenfactor:2.204; Article Influence Score:1.843; JIF Percentile:86.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:108; % of Articles in Citable items:0.6019; Cited Half-Life:5.6; Citing Half-Life:7.7; % of OA Gold:0.9833; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLANDS,
投票 SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影響因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (PHARMACOL  ...234
Total Citations:2769; 2023 JIF:1.963; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:3.461; 5 Year JIF Quartile:Q2; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.405; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:63; JCI Quartile:Q2; JCI Percentile:67.37; Eigenfactor:0.002; Normalized Eigenfactor:0.372; Article Influence Score:0.758; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:69; % of Articles in Citable items:0.913; Cited Half-Life:8.6; Citing Half-Life:8; % of OA Gold:0.1505; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, M
投票 SCIE期刊IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 2024/2025影響因子:2.968 (IMMUNOPHARM IMMUNOT) (0892-3973). (PHARMACOLOGY & PH  ...234
Total Citations:2870; 2023 JIF:2.968; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:3.236; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.8; Immediacy Index-dealt:0.881; 2023 JCI:0.71; JCI Rank: 162/354 ; Total Articles:51; JCI Quartile:Q2; JCI Percentile:54.38; Eigenfactor:0.002; Normalized Eigenfactor:0.449; Article Influence Score:0.612; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:59; % of Articles in Citable items:0.8644; Cited Half-Life:6.7; Citing Half-Life:6.5; % of OA Gold:0.0426; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABING
投票 SCIE期刊JOURNAL OF PHARMACEUTICAL SCIENCES 2024/2025影響因子:3.706 (J PHARM SCI-US) (0022-3549). (PHARMACOLOGY & PHARMACY)(藥理  ...234
Total Citations:26522; 2023 JIF:3.706; JIFRank: 90/354 ; Rank-JIF: 90; Number-of-JIF:354; 5 Year JIF:3.525; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:1.4; Immediacy Index-dealt:1.465; 2023 JCI:0.87; JCI Rank: 109/354 ; Total Articles:271; JCI Quartile:Q2; JCI Percentile:70.35; Eigenfactor:0.009; Normalized Eigenfactor:2.008; Article Influence Score:0.597; JIF Percentile:63.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:297; % of Articles in Citable items:0.9125; Cited Half-Life:11.6; Citing Half-Life:8.6; % of OA Gold:0.1743; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊NEUROTOXICOLOGY 2024/2025影響因子:3.425 (NEUROTOXICOLOGY) (0161-813X). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science Citat  ...234
Total Citations:7562; 2023 JIF:3.425; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.601; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.7; Immediacy Index-dealt:0.724; 2023 JCI:0.98; JCI Rank: 84/354 ; Total Articles:101; JCI Quartile:Q1; JCI Percentile:76.41; Eigenfactor:0.005; Normalized Eigenfactor:1; Article Influence Score:0.738; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:107; % of Articles in Citable items:0.9439; Cited Half-Life:8; Citing Half-Life:8.3; % of OA Gold:0.2743; Publisher name:SPRINGER PUBLISHING CO; Publisher address:11 WEST 42ND STREET, NEW YORK, USA, NY
投票 SCIE期刊Therapeutic Advances in Psychopharmacology 2024/2025影響因子:3.487 (THER ADV PSYCHOPHARM) (2045-1253). (PHARMACOLOGY  ...234
Total Citations:1416; 2023 JIF:3.487; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:4.387; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.3; Immediacy Index:0.9; Immediacy Index-dealt:0.982; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:14; JCI Quartile:Q2; JCI Percentile:58.51; Eigenfactor:0.002; Normalized Eigenfactor:0.461; Article Influence Score:1.285; JIF Percentile:71.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:33; % of Articles in Citable items:0.4242; Cited Half-Life:5.1; Citing Half-Life:6.8; % of OA Gold:0.918; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LONDO
投票 SCIE期刊ANTIVIRAL RESEARCH 2024/2025影響因子:4.589 (ANTIVIR RES) (0166-3542). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science Citati  ...234
Total Citations:11997; 2023 JIF:4.589; JIFRank: 60/354 ; Rank-JIF: 60; Number-of-JIF:354; 5 Year JIF:5.131; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.3; Immediacy Index:1.1; Immediacy Index-dealt:1.107; 2023 JCI:1.76; JCI Rank: 17/354 ; Total Articles:184; JCI Quartile:Q1; JCI Percentile:93.9; Eigenfactor:0.01; Normalized Eigenfactor:2.183; Article Influence Score:1.271; JIF Percentile:79.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:185; % of Articles in Citable items:0.9946; Cited Half-Life:7.3; Citing Half-Life:5.9; % of OA Gold:0.4499; Publisher name:SAGE PUBLICATIONS INC; Publisher address:2455 TELLER RD, THOUSAND OAKS, USA,
投票 SCIE期刊JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 2024/2025影響因子:2.298 (J PHARMACOKINET PHAR) (1567-567X). (PHARMAC  ...234
Total Citations:1728; 2023 JIF:2.298; JIFRank: 204/354 ; Rank-JIF: 204; Number-of-JIF:354; 5 Year JIF:2.435; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.3; Immediacy Index-dealt:0.305; 2023 JCI:0.65; JCI Rank: 177/354 ; Total Articles:37; JCI Quartile:Q2; JCI Percentile:50.14; Eigenfactor:0.001; Normalized Eigenfactor:0.292; Article Influence Score:0.644; JIF Percentile:42.5; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:45; % of Articles in Citable items:0.8222; Cited Half-Life:8.6; Citing Half-Life:7.8; % of OA Gold:0.3889; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unit
投票 SCIE期刊ANTIVIRAL THERAPY 2024/2025影響因子:1.335 (ANTIVIR THER) (1359-6535). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science Citati  ...234
Total Citations:1736; 2023 JIF:1.335; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.548; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.6; Immediacy Index-dealt:0.652; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:17; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.204; Article Influence Score:0.445; JIF Percentile:20.2; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:23; % of Articles in Citable items:0.7391; Cited Half-Life:11.1; Citing Half-Life:6.6; % of OA Gold:0.6184; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Uni
投票 SCIE期刊Marine Drugs 2024/2025影響因子:4.929 (MAR DRUGS) (NULL). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Science Citation Index Expa  ...234
Total Citations:28315; 2023 JIF:4.929; JIFRank: 45/354 ; Rank-JIF: 45; Number-of-JIF:354; 5 Year JIF:5.219; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.2; Immediacy Index:1.3; Immediacy Index-dealt:1.311; 2023 JCI:1.27; JCI Rank: 46/354 ; Total Articles:505; JCI Quartile:Q1; JCI Percentile:87.15; Eigenfactor:0.02; Normalized Eigenfactor:4.422; Article Influence Score:0.73; JIF Percentile:87.4; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:637; % of Articles in Citable items:0.7928; Cited Half-Life:4.6; Citing Half-Life:7.5; % of OA Gold:0.9953; Publisher name:JOHNS HOPKINS UNIV PRESS; Publisher address:JOURNALS PUBLISHING DIVISION, 271
投票 SCIE期刊Environmental Toxicology and Pharmacology 2024/2025影響因子:4.278 (ENVIRON TOXICOL PHAR) (1382-6689). (PHARMACOLOGY &  ...234
Total Citations:9805; 2023 JIF:4.278; JIFRank: 75/354 ; Rank-JIF: 75; Number-of-JIF:354; 5 Year JIF:4.436; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.9; Immediacy Index:1.1; Immediacy Index-dealt:1.186; 2023 JCI:1.05; JCI Rank: 76/354 ; Total Articles:220; JCI Quartile:Q1; JCI Percentile:78.67; Eigenfactor:0.005; Normalized Eigenfactor:1.2; Article Influence Score:0.753; JIF Percentile:79; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:224; % of Articles in Citable items:0.9821; Cited Half-Life:7; Citing Half-Life:6.8; % of OA Gold:0.1748; Publisher name:SPRINGER INT PUBL AG; Publisher address:GEWERBESTRASSE 11, CHAM, SWITZERLAND, CH-6
投票 SCIE期刊JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS 2024/2025影響因子:1.387 (J PHARMACOL TOX MET) (1056-8719). (PHAR  ...234
Total Citations:2381; 2023 JIF:1.387; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.567; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.7; Immediacy Index-dealt:0.704; 2023 JCI:0.45; JCI Rank: 254/354 ; Total Articles:38; JCI Quartile:Q4; JCI Percentile:14.62; Eigenfactor:0.001; Normalized Eigenfactor:0.201; Article Influence Score:0.356; JIF Percentile:9.9; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:38; % of Articles in Citable items:1; Cited Half-Life:10.7; Citing Half-Life:9.4; % of OA Gold:0.3357; Publisher name:ACCSCIENCE PUBLISHING; Publisher address:8 Burn Road#15-03 Trivex, Singapore, Si
投票 SCIE期刊Journal of Pharmacological Sciences 2024/2025影響因子:3.176 (J PHARMACOL SCI) (1347-8613). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:4726; 2023 JIF:3.176; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.109; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.5; Immediacy Index-dealt:0.596; 2023 JCI:0.88; JCI Rank: 105/354 ; Total Articles:72; JCI Quartile:Q2; JCI Percentile:70.48; Eigenfactor:0.003; Normalized Eigenfactor:0.637; Article Influence Score:0.585; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:74; % of Articles in Citable items:0.973; Cited Half-Life:8.3; Citing Half-Life:8.2; % of OA Gold:0.9545; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29
投票 SCIE期刊BEHAVIOURAL PHARMACOLOGY 2024/2025影響因子:1.624 (BEHAV PHARMACOL) (0955-8810). (PHARMACOLOGY & PHARMACY)(藥理學(xué)與藥學(xué))Scie  ...234
Total Citations:2290; 2023 JIF:1.624; JIFRank: 259/354 ; Rank-JIF: 259; Number-of-JIF:354; 5 Year JIF:1.931; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.5; Immediacy Index:0.4; Immediacy Index-dealt:0.424; 2023 JCI:0.51; JCI Rank: 232/354 ; Total Articles:46; JCI Quartile:Q4; JCI Percentile:23.06; Eigenfactor:0.001; Normalized Eigenfactor:0.276; Article Influence Score:0.451; JIF Percentile:16; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:48; % of Articles in Citable items:0.9583; Cited Half-Life:10.7; Citing Half-Life:10.1; % of OA Gold:0.0123; Publisher name:ELSEVIER SCIENCE INC; Publisher address:STE 800, 230 PARK AVE, NEW YORK, US
下一頁 »
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-24 12:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
返回頂部 返回版塊
绩溪县| 青铜峡市| 城口县| 辽阳市| 东源县| 岗巴县| 克拉玛依市| 会理县| 伊川县| 江油市| 三门峡市| 武汉市| 贡山| 嘉峪关市| 漳州市| 芷江| 桃江县| 新泰市| 乐东| 辽宁省| 南江县| 永清县| 望谟县| 唐海县| 安徽省| 台南市| 广德县| 鹤峰县| 英吉沙县| 苍山县| 柳州市| 嘉义市| 武邑县| 铅山县| 德昌县| 怀宁县| 潞西市| 阿拉善右旗| 南漳县| 九寨沟县| 区。|